Patents by Inventor Ambrish Vyas

Ambrish Vyas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Topical formulations of PDE-4 inhibitors and their methods of use
    Patent number: 10357495
    Abstract: Embodiments herein are directed to topical formulations of a compound represented by the formula (I), salt, metabolite, prodrug, or hydrate thereof along with a solvent, and a base. The compound is a PDE4 inhibitor and the topical formulations may be used to treat dermatological conditions such as, but not limited to, atopic dermatitis, seborrheic dermatitis, alopecia, contact dermatitis, psoriasis, urticaria, eczema, burns, sunburn, pancreatitis, hepatitis, lichen planus, scleritis, scleroderma, dermatomyositis, itching associated with any of the preceding conditions or a combination thereof.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: July 23, 2019
    Assignees: DERMAVANT SCIENCES GMBH, EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Ambrish Vyas, Seiji Takemoto, Yoshihiro Akimoto
  • Topical formulations of PDE-4 inhibitors and their methods of use
    Patent number: 10206925
    Abstract: Embodiments herein are directed to topical formulations of a compound represented by the formula (I), salt, metabolite, prodrug, or hydrate thereof along with a solvent, and a base. The compound is a PDE4 inhibitor and the topical formulations may be used to treat dermatological conditions such as, but not limited to, atopic dermatitis, seborrheic dermatitis, alopecia, contact dermatitis, psoriasis, urticaria, eczema, burns, sunburn, pancreatitis, hepatitis, lichen planus, scleritis, scleroderma, dermatomyositis, itching associated with any of the preceding conditions or a combination thereof.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: February 19, 2019
    Assignees: Eisai R&D Management Co, Ltd., Dermavant Sciences GmbH
    Inventors: Ambrish Vyas, Seiji Takemoto, Yoshihiro Akimoto
  • Thiazoloindolinone compounds
    Patent number: 6492398
    Abstract: Thiazole-indole compounds useful as cyclin dependent kinase 11 inhibitors, for preventing/reducing the severity of epithelial cytotoxicity side-effects (e.g., alopecia, plantar-palmar syndrome, mucositis) induced by chemoptherapy and/or radiation therapy in a patient receiving such therapy.
    Type: Grant
    Filed: August 28, 2001
    Date of Patent: December 10, 2002
    Assignee: SmithKline Beechman Corporation
    Inventor: Ambrish Vyas